CALL or TEXT 727-999-3119
DELIVERING BETTER OUTCOMES & REDUCING HEALTHCARE COSTS
PHYSIOLOGIC INSULIN RESENSITIZATION
Finally, a groundbreaking approach designed to provide physicians with a tool that addresses the primary cause of metabolic disorder instead of only suppressing the symptoms.
Neuropathy
Kidney Failure
Dementia
Energy Weight Loss More!
METABOLIC DISORDER
IMPROVEMENTS REPORTED
Neuropathy Improved
40
%
HbA1c Reduction
40
%
Improvement in at least one complication
40
%
Medications Reduced
15
%
PHYSICIAN-DIRECTED
PHYSIOLOGIC INSULIN RESENSITIZATION
FDA APPROVALS
FDA Approved Infusion Device FDA Approved Infusion Biologic
DOMESTIC & INTERNATIONAL LOCATIONS
Physician, academia and government agencies licensed across our brands and growing. We’d love for your location to become our next.
TARGETING PRIMARY CAUSE OF METABOLIC DISORDERS
An adjunct modality that addresses the primary cause of metabolic disorders.
MULTI-PATENTED
Multi-patented and patents pending.
THE SCIENCE BEHIND
PHYSIOLOGIC INSULIN RESENSITIZATION
WHAT IS PHYSIOLOGIC INSULIN RESENSITIZATION?
Well Cell provides a unique and groundbreaking patented approach called Physiologic Insulin Resensitization where insulin is administered as a hormone rather than a drug; addressing the primary cause of Diabetes which is metabolic failure. By utilizing insulin in a manner that bio-mimics normal physiology, this modality is designed to reduce insulin resistance which helps blood sugar more readily enter each cell and be converted into energy.
Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. Thus, our approach not only stabilizes but in many instances has reversed complications of diabetes and other metabolic disorders.
PHYSIOLOGIC ADMINISTRATION
By delivering insulin in a manner that bio-mimics normal physiology, we are able to up-regulate insulin receptor activity and reduce insulin resistance.
INSULIN AS A HORMONE VS A DRUG
What makes this modality unique is using insulin as a hormone rather than a drug.
INSULIN AS A HORMONE VS A DRUG
The treatment is designed to reduce insulin resistance, which is the primary cause of type 2 diabetes and other metabolic disorders.
- The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
- The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
- The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
- Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
- Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
- Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
RESTORING, REPAIRING, REGENERATING, BUT NOT A CURE
Unfortunately, metabolic impairment is a chronic disease. If patients stop therapy, the improvements experienced from these treatments will diminish over time.
Ready to become a Licensee and want to move forward Below are next steps.
Each Licensed location requires a Facility License.
Next Steps:
- Completion of the Facility License Application- We will send this Application to you electronically when ready.
- Styling of the Facility License Agreement based on the Facility License Application and background checks
- Choose package size in the License Agreement (4,8,12,16 pump/see attached)
- Remit funds upon License Application approval, execution and submitted invoice.
- Choose training dates (2023 Houston dates attached)
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
Improved Kidney Function Following Physiologic Insulin Resensitization Treatment Modality
Case Series: Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization
Well Cell Support needs a minimum of three weeks, after receipt of funds, to process and prepare equipment. During this three-week period, prior to training, it is imperative to get the clinic set up and marketing underway to start treating patients on the Monday after the “Infusion Pilots” return from training. The trainees will also have to complete our LMS remote learning platform (approx. 5 hours) prior to their training date in Houston.
What Patients are Reporting
Improved Neuropathy
95%
Report Improvement in at least one diabetic complication
95%
Report HbA1c reduction
95%
Reduced diabetic medications
95%